Clincosm LogoSign in Get a demo

Non-small Cell Lung Cancer

Showing 26 - 50 of 1,515
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CX3CR1+T Cell Predict Immunotherapy Efficacy

Recruiting
  • Non-small Cell Lung Cancer
  • PD-1 inhibitor based immunotherapy
  • Changsha, Hunan, China
  • +1 more
Sep 19, 2023

Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer Trial in Austin, San Antonio, Fairfax (BDC-3042,

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Austin, Texas
  • +2 more
Sep 19, 2023

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Befotertinib + Icotinib placebo
  • Icotinib + Befotertinib placebo
  • Beijing, China
  • +2 more
Sep 20, 2023

Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

Not yet recruiting
  • Diffuse Astrocytoma, IDH-Mutant
  • +20 more
  • NEO212 Oral Capsule
  • +8 more
  • (no location specified)
Sep 18, 2023

Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 18, 2023

NSCLC Trial in Omaha (PLB1004)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Sep 19, 2023

NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Fairfax, Virginia
    NEXT Virginia
Sep 18, 2023

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

Not yet recruiting
  • Carcinoma
  • +7 more
  • XNW5004
  • Pembrolizumab 25 mg/mL Solution for Injection
  • (no location specified)
Aug 31, 2023

Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

Recruiting
  • Brain Metastases
  • Non-small Cell Lung Cancer
  • EGFR-TK Inhibitor
  • Stereotactic radiotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 27, 2023

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

Recruiting
  • Non-small Cell Lung Cancer
    • Guanzhou, China
      Sun Yat-sen University Cancer Center
    Aug 11, 2023

    NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Crizotinib - Usual
    • Crizotinib - Study
    • Rockville, Maryland
      Medicine Invention Design, Inc. - IORG0007849
    Aug 15, 2023

    NSCLC Trial in Guangzhou (PLB1001)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Aug 15, 2023

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Aug 10, 2023

    NSCLC Trial (ABBV-400)

    Available
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Aug 1, 2023

    Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

    Recruiting
    • Non-Small Cell Lung Cancer
    • Neoadjuvant immunochemotherapy
    • Neoadjuvant chemotherapy
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Aug 1, 2023

    NSCLC Trial in Shanghai

    Not yet recruiting
    • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 20, 2023

      NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Tirelizumab；Chemotherapy monotherapy
      • (no location specified)
      Jul 27, 2023

      NSCLC, Nasopharyngeal Carcinoma Trial in China (BL-B01D1, SI-B003)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Nasopharyngeal Carcinoma
      • Chongqing, Chongqing, China
      • +15 more
      Jul 13, 2023

      NSCLC Trial in Guangzhou (TGRX-326)

      Recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 18, 2023

      Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)

      Not yet recruiting
      • Colorectal Cancer
      • Non-Small Cell Lung Cancer
      • (no location specified)
      Jul 12, 2023

      NSCLC Trial in Shanghai (BL-M02D1)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 10, 2023